Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material

Journal of Alzheimer's Disease

Volumn 14, Issue 2, 2008, Pages 235-245

  Collingwood, Joanna F ^a   Chong, Ryan K K ^b   Kasama, Takeshi ^b,c   Cervera Gontard, Lionel ^b   Dunin Borkowski, Rafal E ^b,c,d   Perry, George ^e,f   Pósfai, Mihály ^g   Siedlak, Sandra L ^e   Simpson, Edward T ^b   Smith, Mark A ^e   Dobson, Jon ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^d TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

^f University of San Antonio   (United States)

^g UNIVERSITY OF PANNONIA   (Hungary)

Author keywords

Alzheimer's disease; Amyloid; Electron microscopy; Ferritin; Imaging; Iron; Magnetite; Senile plaque core; Tomography

Indexed keywords

FERRIC OXIDE; FERRITIN; IRON DERIVATIVE; MAGNETITE;

ARTICLE; BIOMINERALIZATION; BRAIN TOMOGRAPHY; ELECTRON DIFFRACTION; ELECTRON ENERGY LOSS SPECTROSCOPY; HUMAN; IRON STORAGE; PRIORITY JOURNAL; PROTEIN AGGREGATION; ROENTGEN SPECTROSCOPY; SENILE PLAQUE; THREE DIMENSIONAL IMAGING; TRANSMISSION ELECTRON MICROSCOPY;

EID: 47849086918     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2008-14211     Document Type: Article

References (60)

1. G. Bartzokis, T.A. Tishler, P.H. Lua, P. Villablanca, L.L. Altshuler, M. Carter, D. Huanga, N. Edwards and J. Mintz, Brain ferritin may influence age- and gender-related risks of neurodegeneration, Neurobiol Aging 28 (2007), 414-423.
2. D. Beauchemin and R. Kisilevsky, A method based on ICP-MS for the analysis of Alzheimer's amyloid plaques, Anal Chem 70 (1998), 1026-1029.
3. P. Blocq and G. Marinesco, Sur les lesions et la pathogenie de l'epilepsie die essentielle, Sem Med 12 (1892), 445-446.
4. F. Brem, A.M. Hirt, M. Winklhofer, K. Frei, Y. Yonekawa, H.G. Wieser and J. Dobson, Magnetic iron compounds in the human brain: a comparison of tumour and hippocampal tissue, J R Soc Interface 3 (2006), 833-841.
5. R.J. Castellani, S.L. Siedlak, G. Perry and M.A. Smith, Sequestration of iron by Lewy bodies in Parkinson's disease, Acta Neuropathol 100 (2000), 111-114.
6. R.J. Castellani, H.G. Lee, X. Zhu, A. Nunomura, G. Perry and M.A. Smith, Neuropathology of Alzheimer disease: pathognomonic but not pathogenic, Acta Neuropathol (Berl) 111 (2006), 503-509.
7. R.J. Castellani, P.I. Moreira, G. Liu, J. Dobson, G. Perry, M.A. Smith and X. Zhu, Iron: the redox-active center of oxidative stress in Alzheimer disease, Neurochem Res 32 (2007), 1640-1645.
8. N.D. Chasteen and P.M. Harrison, Mineralization in ferritin: an efficient means of iron storage, J Struct Biol 126 (1999), 182-194.
9. J.F. Collingwood, A. Mikhaylova, M. Davidson, C. Batich, W.J. Streit, J. Terry and J. Dobson, In situ characterization and mapping of iron compounds in Alzheimer's tissue, J Alzheimers Dis 7 (2005), 267-272.
10. J.F. Collingwood and J. Dobson, Mapping and characterization of iron compounds in Alzheimer's tissue, J Alzheimers Dis 10 (2006), 215-222.
11. J.F. Collingwood and J. Dobson, Nanoscale iron compounds related to neurodegenerative disorders, in: Biomedical Nanostructures, K.E. Gonsalves, C.R. Halberstadt, C.T. Laurencin and L.S. Nair, eds, John Wiley & Sons, New Jersey, 2007, pp. 461-490.
12. J.R. Connor, B.S. Snyder, P. Arosio, D.A. Loeffler and P. LeWitt, A quantitative analysis of isoferritins in selected regions of aged, parkinsonian, and Alzheimer's diseased brains, J Neurochem 65 (1995), 717-724.
13. J.M. Cowley, D.E. Janney, R.C. Gerkin and P.R. Buseck, The structure of ferritin cores determined by electron nanodiffraction, J Struct Biol 13 (2000), 210-216.
14. D.A. DeWitt, G. Perry, M. Cohen, C. Doller and J. Silver, Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease, Exp Neurology 149 (1998), 329-340.
15. J. Dong, C.S. Atwood, V.E. Anderson, S.L. Siedlak, M.A. Smith, G. Perry and P.R. Carey, Metal binding and oxidation of amyloid-β within isolated senile plaque cores: Raman microscopic evidence, Biochemistry 42 (2003), 2768-2773.
16. R.E. Dunin-Borkowski, M.R. McCartney and D.J. Smith, in: Encyclopaedia of Nanoscience and Nanotechnology, (Vol. 3), H.S. Nalwa, ed., American Scientific Publishers, 2004, pp. 41-100.
17. R.F. Egerton, Electron Energy-loss Spectroscopy in the Electron Microscope, Plenum Press, New York, 1986.
18. C. Faber, B. Zahneisen, F. Tippmann, A. Schroeder and F. Fahrenholz, Gradient-echo and CRAZED imaging for minute detection of Alzheimer plaques in an APPV717I x ADAM10-dn mouse model, Magn Reson Med 57 (2007), 696-703.
19. J.C. Fiala, Mechanisms of amyloid plaque pathogenesis, Acta Neuropathologica 114 (2007), 551-571.
20. M.H. Gass, K.K.Koziol, A.H.Windle and P.A. Midgley, Four-dimensional spectral tomography of carbonaceous nanocomposites, Nano Letters 6 (2006), 376-379.
21. B.B. Gelman, Iron in CNS disease, J Neuropathol Exp Neurol 54 (1995), 477-486.
22. L. Goodman, Alzheimer's disease - a clinicopathologic analysis of 23 cases with a theory on pathogenesis, J Nerv Ment Dis 118 (1953), 97-130.
23. B. Hallgren and P. Sourander, The non-haemin iron in the cerebral cortex in Alzheimer's disease, J Neurochem 3 (1958), 41-51.
24. D. Hautot, Q.A. Pankhurst, N. Khan and J. Dobson, Preliminary evaluation of nanoscale biogenic magnetite and Alzheimer's disease, Proc Royal Soc Lon B: Biol Lett 270 (2003), S62-S64.
25. D. Hautot, Q.A. Pankhurst, C.M. Morris, A. Curtis, J. Burn and J. Dobson, Preliminary observation of elevated levels of nanocrystalline iron in the basal ganglia of neuroferritinopathy patients, Biochim Biophys Acta 1772 (2007), 21-25.
26. E. House, J. Collingwood, A. Khan, O. Korchazkina, G. Berthon and C. Exley, Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Aβ42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease, J Alzheimers Dis 6 (2004), 291-301.
27. 2) with iron concentrations in postmortem brain tissue from Alzheimer's disease patients, Magn Reson Med 57 (2007), 172-180.
28. C.R. Jack, T.M. Wengenack, D.A. Reyes, M. Garwood, G.L. Curran, B.J. Borowski, J. Lin, G.M. Preboske, S.S. Holasek, G. Adriany and J.F. Poduslo, In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice, J Neurosci 25 (2005), 10041-10048.
29. D.E. Janney, J.M. Cowley and P.R. Buseck, Structure of synthetic 2-line ferrihydrite by electron nanodiffraction, Amer Mineral 85 (2000), 1180-1187.
30. D.E. Janney, J.M. Cowley and P.R. Buseck, Transmission electron microscopy of synthetic 2- and 6-line ferrihydrite, Clays Clay Miner 48 (2000), 111-119.
31. S. Kato, T. Gondo, Y. Hoshii, M. Takahashi, M. Yamada and T. Ishihara, Confocal observation of senile plaques in Alzheimer's disease: Senile plaque morphology and relationship between senile plaques and astrocytes, Pathol Int 48 (1998), 332-340.
32. M. Kawai, P. Cras and G. Perry, Serial reconstruction of amyloid plaques: Relationship to microvessels and size distribution, Brain Res 592 (1992), 278-282.
33. Y. Ke and Z. Qian, Iron misregulation in the brain: a primary cause of neurodegenerative disorders, Lancet Neurol 2 (2003), 246-253.
34. A. Khan, J. Dobson and C. Exley, Redox cycling of iron by Aβ42, Free Radic Biol Med 40 (2006), 557-569.
35. T. Kimura, T. Hisano, H. Yoshida, K. Ueda and T. Miyakawa, Re-evaluation of classic senile plaques by three-dimensional analysis, J Neurol 241 (1994), 624-627.
36. J.L. Kirschvink, A. Kobayashi-Kirschvink and B.J. Woodford, Magnetite biomineralization in the human brain, Proc Natl Acad Sci USA 89 (1992), 7683-7687.
37. S.P. Lee, M.F. Falangola, R.A. Nixon, K. Duff and J.A. Helpern, Visualization of beta-Amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents, Magn Reson Med 52 (2004), 538-544.
38. M.A. Lovell, J.D. Robertson, W.J. Teesdale, J.L. Campbell and W.R. Markesbery, Copper, iron and zinc in Alzheimer's disease senile plaques, J Neurol Sci 158 (1998), 47-52.
39. M.W. Marlatt, K.M. Webber, P.I. Moreira, H. Lee, G. Casadesus, K. Honda, X. Zhu, G. Perry and M.A. Smith, Therapeutic opportunities in Alzheimer disease: one for all or all for one? Curr Med Chem 12 (2005), 1137-1147.
40. E. Masliah, M. Mallory, T. Deerinck, R. DeTeresa, S. Lamont, A. Miller, R.D. Terry, B. Carragher and M. Ellisman, Re-evaluation of the structural organization of neuritic plaques in Alzheimer's disease, J Neuropath Exp Neurol 52 (1993), 619-632.
41. P.A. Midgley, M. Weyland, J.M. Thomas and B.F.G. Johnson, Z-Contrast tomography: a technique in three-dimensional nanostructural analysis based on Rutherford scattering, Chem Comm 10 (2001), 907-908.
42. Y. Nakata-Kudo, T. Mizuno, K. Yamada, K. Shiga, K. Yoshikawa, S. Mori, T. Nishimura, K. Nakajima and M. Nakagawa, Microbleeds in Alzheimer disease are more related to cerebral amyloid angiopathy than cerebrovascular disease, Dement Geriatr Cogn Disord 22 (2006), 8-14.
43. H. Pardoe, W. Chua-anusorn, T.G. St. Pierre and J. Dobson, Detection limits for ferromagnetic particle concentrations using magnetic resonance imaging-based proton transverse relaxation rate measurements, Phys Med Biol 48 (2003), 89-95.
44. A.E. Porter, M. Gass, K. Muller, J.N. Skepper, P.A. Midgley and M. Welland, Direct imaging of single-walled carbon nanotubes in cells, Nat Nanotechnol 2 (2007), 713-717.
45. C. Quintana, M. Lancin, C. Marhic, M. P'erez, J.Avila and J.L. Carrascosa, Preliminary high-resolution TEM and electron energy-loss spectroscopy studies of ferritin cores extracted from brain in patients with neurodegenerative PSP and Alzheimer diseases, Cell Molec Biol 46 (2000), 807-820.
46. C. Quintana, J.M. Cowley and C. Marhic, Electron diffraction and high-resolution electron microscopy studies of the structure and composition of physiological and pathological ferritin, J Struct Biol 147 (2004), 166-178.
47. C. Quintana, S. Bellefqih, J.Y. Laval, J.L. Guerquin-Kern, T.D. Wu, J. Avila, I. Ferrer, R. Arranz and C. Patiño, Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level, J Struc Biol 153 (2006), 42-54.
48. C. Quintana, About the Presence of Hemosiderin in the Hippocampus of Alzheimer Patients, J Alzheimers Dis 12 (2007), 157-160.
49. C.H. Rickert, T.J. Fuller and F. Gullotta, Three-dimensional reconstruction of senile plaques in Alzheimer's disease, J Microscopy 186 (1997), 263-269.
50. C.A. Rottkamp, A.K. Raina, X. Zhu, E. Gaier, A.I. Bush, C.S. Atwood, M. Chevion, G. Perry and M.A. Smith, Redox-active iron mediates amyloid-β toxicity, Free Radic Biol Med 30 (2001), 447-450.
51. C.A. Rottkamp, C.S. Atwood, J.A. Joseph, A. Nunomura, G. Perry and M.A. Smith, The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease, Peptides 23 (2002), 1333-1341.
52. J.C. Scaiano, S. Monahan and J. Renaud, Dramatic effects of magnetite particles on the dynamics of photogenerated free radicals, Photochem Photobiol 65 (1997), 759-762.
53. D. Schubert and M. Chevion, The role of iron in beta amyloid toxicity, Biochem Biophys Res Comm 216 (1995), 702-707.
54. M.A. Smith, P.L.R. Harris, L.M. Sayre and G. Perry, Iron accumulation in Alzheimer disease is a source of redox-generated free radicals, Proc Natl Acad Sci USA 94 (1997), 9866-9868.
55. C.R. Timmel, U. Till, B. Brocklehurst, K.A. McLauchlan and P.J. Hore, Effects of weak magnetic fields on free radical recombination reactions, Mol Phys 95 (1998), 71-89.
56. J. Wegiel and H.M. Wisniewski, The complex of microglial cells and amyloid star in three-dimensional reconstruction, Acta Neuropathol 81 (1990), 116-124.
57. H.M. Wisniewski, A.W. Vorbrodt, J. Weigel, J. Morys and A.S. Lossinsky, Ultrastructure of the cells forming amyloid fibres in Alzheimer disease and scrapie, Am J Med Gen Suppl 7 (1990), 287-297.
58. L. Zecca, M.B. Youdim, P. Riederer, J.R. Connor and R.R. Crichton, Iron, brain ageing and neurodegenerative disorders, Nat Rev Neurosci 5 (2004), 863-873.
59. L. Zecca, M. Gallorini, V. Schünemann, A.X. Trautwein, M. Gerlach, P. Riederer, P. Vezzoni and D. Tampellini, Iron, neuromelanin and ferritin in substantia nigra of normal subjects at different ages. Consequences for iron storage and neurodegenerative disorders, J Neurochem 76 (2001), 1766-1773.
60. G. Zhao, F. Bou-Abdallah, P. Arosio, S. Levi, C. Janus-Chandler and N.D. Chasteen, Multiple pathways for mineral core formation in mamallian apoferritin: The role of hydrogen peroxide, Biochemistry 42 (2003), 3142-3150.